article

1. Journal of Managed Care.  Journal of managed care & specialty pharmacy.  30:736-746. 2024
2. Association between a national behavioral weight management program and real-world weight change..  Obesity research & clinical practice.  18:201-208. 2024
3. Impact of comprehensive medication reviews on potentially inappropriate medication discontinuation in Medicare beneficiaries..  Journal of the American Geriatrics Society.  72:2347-2358. 2024
4. Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program..  Journal of managed care & specialty pharmacy.  30:609-616. 2024
5. Deprescribing in older adults with polypharmacy..  BMJ (Clinical research ed.).  -. 2024
6. Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure..  JAMA health forum.  5:-. 2024
7. Differences in healthcare costs over 10 years following discharge from military service by weight trajectory..  Obesity research & clinical practice.  18:88-93. 2024
8. Patient Risk-Benefit Preferences for Transcatheter Versus Surgical Mitral Valve Repair..  Journal of the American Heart Association.  13:-. 2024
9. Association Between a National Behavioral Weight Management Program and Veterans Affairs Health Expenditures..  Medical care.  62:235-242. 2024
10. A primer on brand-name prescription drug reimbursement in the United States..  Journal of managed care & specialty pharmacy.  30:99-106. 2024
11. Impact of medication therapy management programs on potentially inappropriate medication use in older adults: A systematic review..  Journal of managed care & specialty pharmacy.  30:3-14. 2024
12. Mapping potentially inappropriate medications in older adults using the Anatomical Therapeutic Chemical (ATC) classification system..  Journal of the American Geriatrics Society.  72:126-138. 2023
13. Patient Preferences for Postmastectomy Breast Reconstruction..  JAMA surgery.  158:1285-1292. 2023
14. Real World Use of Anti-Obesity Medications and Weight Change in Veterans..  Journal of general internal medicine.  39:519-528. 2023
15. Development and Validation of a Tool to Identify Patients Diagnosed With Castration-Resistant Prostate Cancer..  JCO clinical cancer informatics.  -. 2023
16. Considering pharmacoequity when deprescribing potentially inappropriate medications..  Journal of the American Geriatrics Society.  71:1698-1700. 2023
17. Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer..  Seminars in oncology.  50:11-24. 2023
18. Bariatric Surgery and Suicide Risk in Patients With Obesity..  Annals of surgery.  278:e760-e765. 2023
19. Value assessment of deprescribing interventions: Suggestions for improvement..  Journal of the American Geriatrics Society.  71:2023-2027. 2023
20. Cost-Utility Analysis of a Medication Adherence-Enhancing Educational Intervention for Glaucoma..  Ophthalmology. Glaucoma.  6:395-404. 2023
21. Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs..  PloS one.  18:-. 2023
22. BMI Trends for Veterans Up to 10 Years After VA Enrollment Following Military Discharge..  Journal of general internal medicine.  38:1-1430. 2022
23. Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use..  JAMA cardiology.  7:945-952. 2022
24. Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma..  American journal of ophthalmology.  216-227. 2022
25. Deprescribing medications: Do out-of-pocket costs have a role?.  Journal of the American Geriatrics Society.  70:3334-3337. 2022
26. COVID-19 vaccination intention and activation among health care system employees: A mixed methods study..  Vaccine.  40:5141-5152. 2022
27. How a Medicare payment model is affecting care for older adults with Alzheimer's disease and related dementias..  Journal of the American Geriatrics Society.  70:2478-2480. 2022
28. Potential Targets for Deprescribing in Medically Complex Older Adults with Suspected Cognitive Impairment..  Geriatrics (Basel, Switzerland).  7. 2022
29. Formulary tiers, medication cost sharing, and transparency in bronze and silver qualified health plans in 2014 vs 2018..  Journal of managed care & specialty pharmacy.  27:1332-1340. 2021
30. Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer..  BMC cancer.  21:-. 2021
31. Impact of financial medication assistance on medication adherence: a systematic review..  Journal of managed care & specialty pharmacy.  27:924-935. 2021
32. Heterogeneity in Parent Preferences for Peanut Desensitization Therapy..  The journal of allergy and clinical immunology. In practice.  9:3459-3465. 2021
33. Subgroups of High-Risk Veterans Affairs Patients Based on Social Determinants of Health Predict Risk of Future Hospitalization..  Medical care.  59:410-417. 2021
34. Physical Therapy Use, Costs, and Value for Latent Classes of Good vs Poor Outcome in Patients Who Catastrophize About Their Pain Prior to Knee Arthroplasty..  Archives of physical medicine and rehabilitation.  102:1347-1351. 2021
35. EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer..  Cancer treatment and research communications.  -. 2021
36. Randomized controlled trial of an education-based intervention to improve medication adherence: Design considerations in the medication adherence in glaucoma to improve care study..  Clinical trials (London, England).  18:343-350. 2021
37. Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamide..  Journal of managed care & specialty pharmacy.  26:1582-1588. 2020
38. A data-driven examination of which patients follow trial protocol..  Contemporary clinical trials communications.  -. 2020
39. Letter to the Editor on: Formal Physical Therapy Following Total Hip and Knee Arthroplasty Incurs Additional Cost Without Improving Outcomes..  The Journal of arthroplasty.  35:3779-3780. 2020
40. High-Deductible Health Plans and Health Savings Accounts: A Match Made in Heaven but Not for This Irrational World..  JAMA network open.  3:-. 2020
41. Site engagement for multi-site clinical trials..  Contemporary clinical trials communications.  -. 2020
42. Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population..  Journal of managed care & specialty pharmacy.  26:169-175. 2020
43. Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools..  Journal of managed care & specialty pharmacy.  25:342-349. 2019